JPMorgan Taps William Blair’s Kallop for Strategic Investor M&A
JPMorgan Chase & Co. has hired William Kallop from William Blair & Co. for its mergers and acquisitions group focused on ...
ETF Daily News3d
Q2 EPS Estimates for Ovid Therapeutics Cut by William Blair
William Blair also issued estimates for Ovid Therapeutics’ Q3 2025 earnings at ($0.16) EPS, Q4 2025 earnings at ($0.17) EPS, FY2025 earnings at ($0.61) EPS and FY2026 earnings at ($0.74) EPS ...
Hosted on MSN1mon
Tempus AI stock downgraded by William Blair after massive rally
Investing.com -- William Blair downgraded Tempus AI Inc (NASDAQ:TEM) to "Market Perform" from "Outperform" given stock's sharp rally rather than any concerns over the company’s fundamentals.
What is William Blair’s Estimate for TNYA Q1 Earnings?
Investment analysts at William Blair issued their Q1 2025 earnings per share (EPS) estimates for Tenaya Therapeutics in a research report issued to clients and investors on Monday, March 10th. William ...